Clinical Pipeline

Endocrinology

abbvie_logo

Endometriosis

elagolix

Pre-Clinical Phase 1 Phase 2 Phase 3 NDA Filed 2016
abbvie_logo

Uterine Fibroids

elagolix

Pre-Clinical Phase 1 Phase 2 Phase 3 NDA Filed 2016
abbvie_logo

Women's/Men's Health

GnRH Antagonist

Pre-Clinical Phase 1 Phase 2 Phase 3 NDA Filed 2016 2016 2016

Congenital Adrenal Hyperplasia

Pre-Clinical Phase 1 Phase 2 Phase 3 NDA Filed 2016 2016

Central Nervous System

Tardive Dyskinesia

NBI-98854

Pre-Clinical Phase 1 Phase 2 Phase 3 NDA Filed 2016 2016

Tourette Syndrome

NBI-98854

Pre-Clinical Phase 1 Phase 2 Phase 3 NDA Filed 2016 2016